Aktiesnakken — Januar 2012
-
keno
-
jeg elsker medister
-
dejlig saftig pølse
-
Genmab/Kempen: Skærer kursmål til 65 kr pr aktie
12:08
Kursmålet på aktien i biotekselskabet Genmab er blevet skåret til 65 kr. fra tidligere 85 kr. pr. aktie af analytikerne i finanshuset Kempen. Anbefalingen lyder fortsat på køb. Det fremgår af data fra Bloomberg News.Kursmålet indikerer et potentiale på 81 pct. i forhold til kursen tirsdag på 35,91.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind